Literature DB >> 6859457

Effect of subcutaneous desferrioxamine on iron balance in young thalassemia major patients.

S De Virgiliis, P Cossu, C Toccafondi, G Sanna, F Frau, R Lobrano, G Cornacchia, A Nucaro, A Loi, F Bertolino, A Cao.   

Abstract

In this study we evaluated the effect of 1-year, subcutaneous desferrioxamine daily infusion on iron balance in 23 thalassemia major children, aged 8-74 months, with transfusional iron accumulation less than 3.8 g at the outset of the trial. Statistical analysis showed a significant correlation between transfusional iron accumulation and percentage of transfusional iron eliminated. Confidence limits analysis of these data indicated that over 3.5 g of transfusional iron load, 95% of the patients may achieve balance. The appropriate time to begin desferrioxamine infusion, therefore, seems to be after about 30 transfusions of packed red blood cells when iron accumulation of approximately 3 g is reached. As we found a statistically significant correlation between transfusional iron eliminated and serum ferritin levels, the evaluation of serum ferritin alone can also predict when balance can be obtained.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6859457

Source DB:  PubMed          Journal:  Am J Pediatr Hematol Oncol        ISSN: 0192-8562


  4 in total

1.  Growth plate injury of the long bones in treated beta-thalassemia.

Authors:  C Orzincolo; P N Scutellari; G Castaldi
Journal:  Skeletal Radiol       Date:  1992       Impact factor: 2.199

2.  Evaluation of growth, puberty and endocrine dysfunctions in relation to iron overload in multi transfused Indian thalassemia patients.

Authors:  Rashid H Merchant; Amruta Shirodkar; Javed Ahmed
Journal:  Indian J Pediatr       Date:  2011-01-14       Impact factor: 1.967

3.  Depletion of trace elements and acute ocular toxicity induced by desferrioxamine in patients with thalassaemia.

Authors:  S De Virgiliis; M Congia; M P Turco; F Frau; C Dessi; F Argiolu; R Sorcinelli; A Sitzia; A Cao
Journal:  Arch Dis Child       Date:  1988-03       Impact factor: 3.791

4.  Studies of variations of subcutaneously infused desferrioxamine and iron movements in thalassaemia children.

Authors:  E A Llados i Vallory; R Girot; G Lenoir; M Payet; P Houze; R Bourdon
Journal:  Eur J Pediatr       Date:  1989-04       Impact factor: 3.183

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.